Literature DB >> 27383076

Interventional cardiology: Polymer-free drug-eluting stents - a safe and effective option for ACS.

Yukinori Harada1, Adnan Kastrati1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27383076     DOI： 10.1038/nrcardio.2016.110

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.

Authors:  Julinda Mehilli; Adnan Kastrati; Rainer Wessely; Alban Dibra; Jörg Hausleiter; Birgit Jaschke; Josef Dirschinger; Albert Schömig
Journal:  Circulation       Date:  2006-01-03       Impact factor: 29.690

2.  Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology.

Authors:  Philippe Gabriel Steg; Kurt Huber; Felicita Andreotti; Harald Arnesen; Dan Atar; Lina Badimon; Jean-Pierre Bassand; Raffaele De Caterina; John A Eikelboom; Dietrich Gulba; Martial Hamon; Gérard Helft; Keith A A Fox; Steen D Kristensen; Sunil V Rao; Freek W A Verheugt; Petr Widimsky; Uwe Zeymer; Jean-Philippe Collet
Journal:  Eur Heart J       Date:  2011-06-29       Impact factor: 29.983

3.  Minimising bleeding during percutaneous coronary intervention.

Authors:  Gjin Ndrepepa; Adnan Kastrati
Journal:  BMJ       Date:  2015-03-24

4.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Authors:  Ph Gabriel Steg; Stefan K James; Dan Atar; Luigi P Badano; Carina Blömstrom-Lundqvist; Michael A Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J Lenzen; Kenneth W Mahaffey; Marco Valgimigli; Arnoud van 't Hof; Petr Widimsky; Doron Zahger
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

5.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2016-03-29       Impact factor: 24.094

6.  Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.

Authors:  Tomohisa Tada; Robert A Byrne; Iva Simunovic; Lamin A King; Salvatore Cassese; Michael Joner; Massimiliano Fusaro; Simon Schneider; Stefanie Schulz; Tareq Ibrahim; Ilka Ott; Steffen Massberg; Karl-Ludwig Laugwitz; Adnan Kastrati
Journal:  JACC Cardiovasc Interv       Date:  2013-12       Impact factor: 11.195

7.  Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

Authors:  Philip Urban; Ian T Meredith; Alexandre Abizaid; Stuart J Pocock; Didier Carrié; Christoph Naber; Janusz Lipiecki; Gert Richardt; Andres Iñiguez; Philippe Brunel; Mariano Valdes-Chavarri; Philippe Garot; Suneel Talwar; Jacques Berland; Mohamed Abdellaoui; Franz Eberli; Keith Oldroyd; Robaayah Zambahari; John Gregson; Samantha Greene; Hans-Peter Stoll; Marie-Claude Morice
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

8.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Authors:  Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 9.  Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.

Authors:  Robert A Byrne; Michael Joner; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983

10.  Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.

Authors:  Christoph K Naber; Philip Urban; Paul J Ong; Mariano Valdes-Chavarri; Alexandre A Abizaid; Stuart J Pocock; Franco Fabbiocchi; Christophe Dubois; Samuel Copt; Samantha Greene; Marie-Claude Morice
Journal:  Eur Heart J       Date:  2017-04-01       Impact factor: 29.983
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.